Study Objectives: Rapid eye movement (REM)-induced hypotonia of the major upper airway dilating muscle (genioglossus) potentially contributes to the worsening of obstructive sleep apnea that occurs during this stage. No prior human single motor unit (SMU) study of genioglossus has examined this possibility to our knowledge. We hypothesized that genioglossus SMUs would reduce their activity during stable breathing in both tonic and phasic REM compared to stage N2 sleep. Further, we hypothesized that hypopneas occurring in REM would be associated with coincident reductions in genioglossus SMU activity. Design: The activity of genioglossus SMUs was studied in (1) neighboring epochs of stage N2, and tonic and phasic REM; and (2) during hypopneas occurring in REM. Setting: Sleep laboratory. Participants: 29 subjects (38 ± 13 y) (17 male). Intervention: Natural sleep, including REM sleep and REM hypopneas. Measurement and Results: Subjects slept overnight with genioglossus fine-wire intramuscular electrodes and full polysomnography. Forty-two SMUs firing during one or more of stage N2, tonic REM, or phasic REM were sorted. Twenty inspiratory phasic (IP), 17 inspiratory tonic (IT), and five expiratory tonic (ET) SMUs were characterized. Fewer units were active during phasic REM (23) compared to tonic REM (30) and stage N2 (33). During phasic REM sleep, genioglossus IP and IT SMUs discharged at slower rates and for shorter durations than during stage N2. For example, the SMU peak frequency during phasic REM 5.7 ± 6.6 Hz (mean ± standard deviation) was less than both tonic REM 12.3 ± 9.7 Hz and stage N2 16.1 ± 10.0 Hz (P < 0.001). The peak firing frequencies of IP/IT SMUs decreased from the last breath before to the first breath of a REM hypopnea (11.8 ± 10.9 Hz versus 5.7 ± 9.4 Hz; P = 0.001) Conclusion: Genioglossus SMU activity is significantly reduced in REM, particularly phasic REM. SMU activity decreases abruptly at the onset of REM hypopneas.
INTRODUCTION
Obstructive sleep apnea syndrome (OSAS) is common 1 and has serious sequelae such as road traffic accidents and cardiovascular disease; 2-5 yet, its pathophysiology remains incompletely understood. Due to poor adherence or variable efficacy with the standard treatments, further mechanistic work is required to determine new potential treatment strategies of OSAS. 6, 7 The severity of OSA typically worsens during rapid eye movement (REM) sleep with respiratory events being more common, longer, and associated with more hypoxemia than during stage N2 sleep. 8 Moreover, cardiac ischemia and pulmonary hypertension can occur in susceptible individuals during REM. 9, 10 Understanding the physiological mechanisms underlying the worsening of OSAS during REM is therefore vital and could lead to new therapeutic approaches.
During nonrapid eye movement (NREM) sleep, the major upper airway dilator muscle (genioglossus) shows increased activity in stable breathing compared to periods of cyclical breathing when obstructive apneas occur, 11 suggesting that upper airway dilator muscles are both necessary and sufficient to stabilize the upper airway. Given the stabilizing properties of the genioglossus, 11, 12 it is reasonable to predict that diminished genioglossus activity during REM compared to stage N2 would account for the worsening of OSA during REM. Sauerland and Harper showed that multiunit genioglossus activity is reduced during REM. 13 The physiological mechanisms for this genioglossus hypotonia during REM are not known. Furthermore, no studies to date have compared genioglossus single motor unit (SMU) activity in REM compared to stage N2 in humans or experimental animals.
One multiunit electromyographic (EMG) genioglossus study showed progressively worsening activity going from stage N2 to tonic REM to phasic REM. 14 The exact physiological mechanisms underlying this reduced genioglossus activity are unknown, and another multiunit EMG study did not show increased activity during normal breathing between REM and NREM sleep. 15 Thus, the existing multiunit literature has not fully explained the role of the genioglossus (or other factors) in the worsening of OSAS seen in REM. Therefore, through the analysis of human genioglossus SMUs, we sought to address the effects of REM sleep on the motor output of the genioglossus muscle. We examined genioglossus activity during Upper Airway Hypotonia during REM Sleep-McSharry et al stable breathing and during episodes of hypopneas or obstructive apneas in REM sleep. We hypothesized that SMU activity would be reduced during periods of stable breathing in REM compared to similar periods in stage N2 sleep, thus providing physiological mechanisms for upper airway vulnerability during REM. In addition, we hypothesized that hypoglossal motor output would decrease at the onset of hypopneas in REM sleep.
METHODS

Study Subjects
Ethics approval was granted by the Partners' Institutional Review Board (IRB). Exclusion criteria were: active cardiorespiratory disease, diabetes mellitus or other endocrine disorders, myopathy, pregnancy, neurological illness, or medications that could alter neuromuscular function (e.g., selective serotonin reuptake inhibitors or benzodiazepines). Twenty-nine human volunteers were recruited from advertisements in a local newspaper, website, and our clinical sleep clinic. Baseline demographic information for the 15 subjects who yielded appropriate data (i.e., sortable motor units during one or both of REM and stage N2) is provided in Table 1 (along with those who did not yield sortable units).
Materials and Procedures
Subjects arrived at our Center for Clinical Investigation 3 h before their usual bedtime. All subjects gave written informed consent. Medical assessment and physical examination was carried out by a physician. Pregnancy was excluded with a urinary human chorionic gonadotropin test in all women of childbearing capacity. Topical local anesthetic cream (lidocaine 2.5% / prilocaine 2.5%, E. Fougera & Co., Melville, NY, USA) was applied to the skin posterior to the genial tubercle of the mandible for 30 min prior to fine-wire insertion. Ultrasonography with electronic calipers was performed in the sagittal and coronal planes to define the anatomy to ensure fine-wire electrode placement in the genioglossus (12L high-frequency linear array transducer, Vivid i GE Healthcare, Chalfont St. Giles, Bucks, UK).
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Subjects were instrumented with three electroencephalograms (F3-A2, C3-A2, O2-A1), submental EMG, left and right electrooculograms, and an electrocardiogram with surface electrodes for the duration of their overnight sleep. Subjects were fitted with a nasal mask connected to a pneumotachograph (Hans Rudolph, Shawnee, KS, USA) with differential pressure transducer for measurement of airflow and calculation of ventilation. End-tidal CO 2 (ETCO 2 ) (Vacumed, Ventura, CA, USA) was monitored from one nostril and arterial oxygen saturation (SaO 2 ) measured with finger pulse oximetry. Respiratory effort bands (Protech ZRIP Effort Sensor, Respironics, Mukilteo, WA, USA) were placed on the chest (midsternum) and abdomen (umbilicus).
The final part of the instrumentation was conducted as follows. The local anesthetic cream was removed with sterile alcohol wipes. The subject was asked to lie flat and supine on the bed with one pillow. Fine-wire electrode insertion was conducted similar to the technique of Eastwood et al. 16 A cross was drawn in the midline 10mm posterior to the genial tubercle of the mandible. 16 Three 27-G needles (Franklin Lakes, Becton Dickinson, NJ, USA) were used to guide the three fine-wire electrodes into the genioglossus. Each of these guide needles was immediately removed once the fine-wire electrodes were placed in situ. The fine-wire electrodes were custom made stainless steel Teflon coated wires (0.076-mm bare, 0.14-0 mm coated, A-M Systems, Inc., Carlsborg, WA) hooked over the bevel of each needle with 0.5 mm of insulation removed. The hooked portion was approximately 3-4 mm long. The needles were inserted 90º to the skin surface to a depth determined by the ultrasound. The first needle was inserted 3-5 mm from the center of the marked cross anterolaterally. The second and third needles respectively were inserted 3-5 mm from the center of the cross posterolaterally to the left and right of the midline. The fine-wire electrodes were referenced to a surface electrode placed over the mandible (MEDI-TRACE 100 series, Kendall Healthcare, Mansfield, MA) and grounded to a large electrode placed over the right scapula (1180, 3M Health Care, St. Paul, MN). Finally, the subject's mouth was taped shut to encourage nasal breathing, enabling accurate measurement of flow measured with the pneumotachograph and ETCO 2 measured via nasal probe. If the subject was reluctant to have his or her mouth taped shut, then the study proceeded without mouth tape. The subject was then given the opportunity to sleep for up to 8 h with the fine-wires electrodes in place. All subjects were instructed to sleep supine. When a subject turned on their side during sleep, he or she was awakened after 5 min in this position to facilitate their return to supine sleeping. Genioglossus EMG signals were filtered (10 Hz to 3KHz) and amplified (×1000-20,000) (Model 15, Grass Technologies, Warwick, RI, USA). All signals were recorded on a Spike 2 data acquisition system (Spike2 version 7.03 with 1401 interface, Cambridge Electronic Design, Cambridge, UK). Genioglossus EMG signals were recorded at 25 kHz; electroencephalography, electrooculography, electrocardiography, and submental EMG at 500 Hz; ETCO 2 , airflow and tidal volume at 125 Hz, and SaO 2 at 25 Hz. All data were stored on a computer for offline analysis.
Data Analysis
Sleep Staging and Identification of SMUs
All sleep periods were staged and scored in accordance with the American Academy of Sleep Medicine criteria 17, 18 by a registered polysomnographic technician with airflow used in place of nasal pressure/thermistor. All sleep staging and scoring was performed while blinded to the three genioglossus EMG channels. After the formal scoring of the sleep study, one author (DMcS) chose the areas of data for analysis based on a priori defined criteria. The segments of data used for analysis were chosen from (1) stage N2 -REM (or vice versa) transitions and (2) hypopneas or apneas as follows.
(1) Data from each subject were stored in 1-h files. Each file was opened. In files that contained REM sleep, SMU activity was sought in either REM or stage N2. REM was further classified as tonic or phasic (when rapid eye movements occur). A full epoch (30 sec) of SMU data was thoroughly sorted (each discharge of every motor unit was fully characterized) in each of stage N2 and tonic and phasic REM. Data were not analyzed if they occurred during or less than 10 sec after an apnea, hypopnea or arousal. Snoring or flow limitation that did not meet criteria for an hypopnea 18 did not preclude inclusion. The epochs were chosen as follows: if stage N2 occurred first then the penultimate epoch of stage N2 before REM was sorted. In this instance, the tonic REM epoch for analysis was chosen as the second epoch of REM so as to avoid potentially analyzing stage N2 because the transition is often ill defined. If phasic REM occurred in the second epoch or if an arousal, apnea, or hypopnea occurred, the first available uncomplicated 30-sec segment of tonic REM after this was analyzed. The phasic REM was chosen as the first 30 sec of phasic REM after stage N2. Ideally it was 30 sec of consecutive breaths but if this was not available (due to neighboring arousals, apneas, or hypopneas or usually not enough consecutive phasic REM), then subsequent phasic REM breaths were analyzed to ensure the equivalent of an epoch was scrutinized. Figure 1 shows an example of how we chose our data. This procedure was followed in reverse for occasions when REM occurred first. The middle three breaths of the analyzed data segments in stage N2, phasic REM, and tonic REM were further characterized by measuring detailed respiratory and SMU characteristics. If the unit was not present in a given stage, then the relevant frequency was scored as zero. If subjects breathed through their mouth, then the exact times that the SMU fired with respect to the respiratory cycle could not be calculated. The validity of the SMU frequency characteristics was unaffected by mouth breathing.
(2) The SMU activity before, during, and after hypopneas and obstructive apneas was characterized as follows: SMU activity was sorted and measured for the last two breaths before, the first two breaths of, the last two breaths of, and the two breaths after the hypopnea/apnea. If the unit did not fire during a given breath, then the relevant frequency was scored as zero.
Sorting and Classification of SMUs
Sorting is the process by which each discharge of a SMU is extracted from the raw EMG signal. The SMUs were extracted from the raw EMG signal offline using a Spike-triggered threshold (Spike 2 version 7.03 software, Cambridge Electronic Design, Cambridge, England). Spike templates were identified on the basis of the size and detailed morphology of the motor units. Every single discharge of each motor unit was manually inspected to confirm that it was classified correctly. Manual inspection was facilitated by a computer script (courtesy of the Gandevia Laboratory, Randwick, Sydney, Australia). Instantaneous discharge frequency plots were derived from the time of discharge of the unit.
The activity of each motor unit was classified based on its pattern of discharge during the respiratory cycle; determined from the volume signal. 19, 20 Motor units that fired throughout the respiratory cycle were classified as tonic. Motor units that fired for part of the respiratory cycle were classified as phasic. Motor units were further visually subclassified as inspiratory, expiratory, or other depending on when they fired at their peak discharge frequency. Following the visual classification of the different types of motor units, cross-correlation between volume and instantaneous firing frequency (smoothed over 200 ms) were calculated between the signals on a breath-by-breath basis. The volume signal was derived from the flow signal using a script. Figure 2 shows the instantaneous discharge frequency and the volume signal. The strength of the correlation between these measures [linear coefficient of determination (r 2 )] and the timing of the maximal value of this coefficient, the lag time, were calculated. Time zero is the reference point and represents the end of inspiration. Inspiratory units have a peak r 2 before the end of inspiration (negative lag times), and expiratory units have a peak r 2 after the end of inspiration during expiration (positive lag times). Like the other timing characteristics, the lag times were not calculated for the mouth breathers because they would likely be inaccurate and therefore potentially misleading.
Measurement of Respiratory Variables and Discharge Properties of SMUs
The respiratory variables analyzed [inspiratory time (T I , s), tidal volume (liter), and ETCO 2 (mmHg)] were measured over the three breaths each of stage N2, tonic REM, and phasic REM. Mean values were calculated for each of the three sleep stages yielding three data points. The instantaneous discharge frequency plots of the sorted motor unit were used to identify the discharge behavior (including discharge frequency and discharge duration). All motor unit characteristics reported were calculated from the instantaneous discharge frequency plots using Spike 2 (Spike2 version 7.03, Cambridge Electronic Design) and a custom-developed script (courtesy of the Gandevia Laboratory, Randwick, Sydney, Australia). An example of instantaneous discharge frequency plots are given in Figure 2 . Discharge timing was expressed relative to the integrated flow signal and referenced to the start of inspiration. The discharge timing was calculated as a percentage of the inspiratory time (%T I ). Mean motor unit discharge characteristics were measured over the three continuous breaths and averaged in stage N2, tonic REM, and phasic REM, yielding three data points that allowed comparisons between the sleep stages.
For inspiratory phasic units, the onset discharge time was measured at the first motor unit discharge for each breath and the end time was measured at the last discharge in each breath (Figure 2 ). For inspiratory tonic units, onset time was taken visually from when the discharge frequency first increased above the tonic levels and the end time when the discharge frequency first returned to the tonic level (Figure 1 ). Onset discharge frequency for inspiratory phasic units was calculated from the first interspike interval for each breath (Figure 2 ). The tonic level was the baseline discharge frequency of the inspiratory tonic unit. This tonic level is the tonic expiratory discharge frequency which is measured and averaged over 500 ms (Figure 1 ). Peak discharge frequencies were derived from the peak of the instantaneous frequency with a running average for each breath (smoothed over 200 ms; see Figure 1 ). The mean frequency was calculated over 200 ms.
Statistical Analysis
All results of the SMUs were compared between stage N2 and tonic REM and phasic REM by one-way repeated-measures analysis of variance using SigmaPlot (version 11) statistical software (SigmaPlot, San Jose, CA, USA). If the normality test failed, then the alternative requisite statistical test, E.G. Friedman Repeated Measures Analysis of Variance on Ranks, was performed. The number of units active in each of the three stages was statistically analyzed by chi-square analysis. When comparing data between males and females, t tests were used. When the normality test failed, then the Mann-Whitney ranksum test was performed. The REM-related hypopnea data were analyzed using Wilcoxon signed rank tests. Data are displayed and expressed as mean ± standard deviation (SD) unless otherwise specified. Significance was P < 0.05.
RESULTS
Fifteen of the 29 study subjects yielded sortable SMUs in either REM or stage N2 or both stages. The demographic and polysomnographic details of these 15 subjects and the other 14 for comparative purposes are given in Table 1 . Forty-two SMUs firing during one or another of stage N2, tonic REM, or phasic REM were sorted from these 15 individuals. Twenty inspiratory phasic (IP), 17 inspiratory tonic (IT), and 5 expiratory tonic (ET) SMUs were characterized. Fewer units (23) were active during phasic REM compared to tonic REM (30) and stage N2 (33) (P > 0.05, NS). These data are presented graphically in Figure  2 . Ten of the 15 subjects had OSAS and their polysomnography findings are presented in Table 2 . The mean ± SD number of SMUs per subject was 2.8 ± 1.7. One subject contributed six SMUs. One subject contributed five SMUs. Four subjects each contributed four SMUs. One subject contributed three SMUs. Four subjects each contributed two SMUs. Four subjects each contributed one SMU.
Thirty of the 37 inspiratory units (IP and IT) were fully measured. Of these 30 units, 17 were from subjects who breathed exclusively through their noses. The other seven inspiratory units were not fully measured either because the EMG signals were multiunit in part or if the unit's discharge was not sustained. Pooling these 30 measured inspiratory units together, the onset, peak, end, and mean discharge frequencies were significantly lower in phasic REM compared to both tonic REM and stage N2 (P < 0.05). The tonic expiratory discharge frequency was significantly lower in phasic REM compared to stage N2 but not compared to tonic REM. These data are presented in Table 3 . Eight inspiratory units that remained active during the three stages from subjects who breathed exclusively through their noses showed a shorter duration of discharge during phasic REM compared to both Table 3 . In order to determine the relationship of SMU behavior with respect to obstructive apneas and hypopneas, 14 different SMUs were studied during 15 hypopneas. Twelve of these 14 SMUs were IP units and two were IT units. Genioglossus SMUs had greatly reduced activity at the onset of REM-related hypopneas. The peak discharge frequencies of inspiratory SMUs decreased from the last breath before a hypopnea to the first breath of that hypopnea (11.8 ± 10.9 Hz versus 5.7 ± 9.4 Hz; P = 0.001). At the end of the hypopnea the peak discharge frequencies of inspiratory SMUs increased from the last breath of the hypopnea to the first breath after the hypopnea (4.9 ± 7.5 Hz versus 9.9 ± 8.3 Hz; P = 0.003).
Seven of the 15 subjects who provided sortable SMUs were female. During both tonic and phasic REM, the SMUs behaved similarly in men and women both in terms of overall activity ( Figure 2 ) and firing frequencies. For example, during phasic REM the peak frequencies in males were 5.9 ± 6.9 Hz compared to 5.4 ± 6.2 Hz in females (P = 0.93). During stage N2, the peak frequencies were higher in males than females (19.2 ± 8.8 Hz versus 11.4 ± 10.3; P = 0.04).
DISCUSSION
Overall these data show diminished genioglossus activity during REM (particularly phasic REM) as evidenced by fewer SMUs being active, reduced discharge frequencies, and shorter firing durations. These state-dependent changes likely account for the clinically important hypotonia and the worsening of OSAS during REM sleep. Further support for this idea comes from our discovery of the direct and, we hypothesize, causal relationship between a drop in genioglossus SMU activity coincident with the onset of the REM hypopnea/obstructive apnea ( Figure 3) .
Our findings are novel and are important because understanding the neurochemistry of these units through animal experiments may lead to new therapeutic targets in OSAS and because REM sleep is a potentially hazardous time for some people. 21, 22 Increased cardiac ischemia and pulmonary hypertension 9, 10 can occur more commonly during REM than other sleep stages in susceptible individuals. Figure 4 presents raw data from one of our subjects and illustrates all of our key findings succinctly. In this example, REM heralds a precipitous drop in genioglossus SMU activity and with it a hypopnea. Our findings are consistent with those of our multiunit study (conducted with participants receiving nasal continuous positive airway pressure), which showed that genioglossus activity is reduced from stable NREM, to tonic REM to phasic REM sleep.
14 A potential limitation of our study was that we had to exclude the timing characteristics (such as onset firing time) in the subjects who breathed through their mouth. The exact timing of SMU activity with respect to inspiration cannot be definitively measured in mouth breathers because the pneumotachographs are attached to their noses.
Genioglossus SMU techniques are being increasingly used in upper airway physiology studies, providing insight into the neural output of the hypoglossal motor nucleus. No study had compared genioglossus SMU activity in stage N2 to REM prior to our current study. Wilkinson et al. showed that there was a marked derecruitment of inspiratory SMUs at sleep onset, but expiratory and tonic unit were unaffected by the state transition. 23 These authors speculated that upper airway patency during sleep was dependent on the stiffening properties of expiratory and tonic units. We fully defined five expiratory units REM-related sleep disordered breathing is common in women. 26 There were no significant differences between women and men with respect to body mass index, apnea-hypopnea index, or age. We noted no significant differences in SMU activity between women and men during REM sleep, although the peak discharge frequency was higher in men during stage N2. Therefore, a factor other than diminished genioglossus activity is likely to be responsible for the female preponderance of REM-related apneas. However, we acknowledge that our study was underpowered for subgroup analyses, emphasizing the need for further research.
The cause of the reduced motor output of the genioglossus we have shown particularly in phasic REM is unclear. No significant differences were seen in ETCO 2 between sleep stages. Moreover, changes in ETCO 2 are unlikely to account for the observed changes in firing rate. More likely, state-dependent changes in inputs to genioglossus motoneurons, 27 such as the recently described flip-flop switch (which is composed of gamma-aminobutyric acidergic and glutaminergic neurons), suppress hypoglossal motor nucleus output 21 coincident with REM sleep. Disfacilitation due to loss of excitatory inputs is a favored hypothesis. 27 However, Grace et al. recently showed that genioglossal hypotonia in rats is most likely mediated by REMrelated inhibition by acetylcholine acting on G-protein-coupled inwardly rectifying potassium channels. 22 Neither the source of this cholinergic input nor the nature of interactions between cholinergic, noradrenergic, and other excitatory neurochemicals is understood. Our physiological findings explaining decreased genioglossus activity during REM may help to sort this out. In summary, we have shown reduced activity of genioglossus inspiratory and expiratory SMUs. This hypotonia likely causes the OSAS as further evidenced by the significant decrease in firing frequencies coincident with the start of REM hypopneas. Defining the neurochemistry of these SMUs in animal models could yield new therapeutic targets.
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